The fibrin polymers formed in solution during the earliest phase of the fibrinogen-fibrin conversion are shown to be stable soluble molecules at pH 7.4 and 0.15 M-or 0.3 M-NaCl. The various sequential soluble fibrin polymers produced from the fibrinogen-thrombin reaction can be observed by gel chromatography and can be isolated for characterization. The mechanism of fibrin polymerization proposed from the present studies suggests that the initial event is the thrombin activation at only one of the Aa-chains in fibrinogen. The resulting highly reactive intermediate is the true fibrin monomer and it rapidly, and irreversibly, self-associates to form the stable fibrin dimer (s20.w= 12S). Fibrin dimer possesses the N-terminal pattern alanine/glycine/tyrosine (1:1:2) per 340000 molecular weight, and possesses the chain structure [(a)Aa)(Bfl)2(y)2]2. The fibrin dimer is a soluble inert molecule, but additional thrombin activation of its remaining intact Aa-chains leads to new associations into larger inert soluble fibrin polymers. In this manner progressively larger fibrin oligomers are constructed with thrombin continually in control of the process because of the necessity to repeatedly re-activate the various fibrin polymers in solution. The inert character of the soluble fibrin polymers can be explained by the reciprocal alignment of the associating molecules, which mutually consumes their active surfaces and leaves an intact Aa-chain at either end ofeach fibrin oligomer. The soluble fibrin polymers will proceed to further association only if thrombin activates these remaining Aa-chains, otherwise the fibrin molecules are stable indefinitely. The intermolecular associations within the soluble fibrin polymers are essentially irreversible under these nearly physiological conditions. However, the bonding is not covalent. This mechanism accounts for the clinical observations of stable fibrinogen-derived polymers in the plasma from patients undergoing thrombotic processes. Since it is shown that the intermediate fibrin polymers, themselves, are stable soluble molecules, it is no longer necessary, nor warranted, to invoke hypothetical 'fibrinogen-fibrin complexes' to explain observations of fibrin solubility.
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The conversion of fibrinogen into fibrin is one of the most important biochemical reactions, since blood clotting is a fundamental part of the homoeostatic system, and also because fibrin formation plays important roles in many pathological processes, e.g., overt thrombosis, cancer, diabetes and inflammatory diseases (Zimmerman, 1976; Wessler, 1977) .
Abbreviations used: Bz-Phe-Val-Arg-pNA, benzoylphenylalanylvalylarginine p-nitroanilide; SDS, sodium dodecyl sulphate; Temed, NNN'N'-tetramethyl-ethylenediamine; the three pairs of fibrinogen chains are designated singly as Aa, B,Band y; when the fibrinopeptides have been removed from the Aa-and Bfl-chains, the chain designations become a and respectively; thus the three pairs of fibrinogen chains, as a molecule, are designated as (Aa)2(B/i)2(y)2, whereas fully thrombin-proteolysed fibrinogen is designated as (0)2(602()2; Accordingly, the chemical reactions that produce fibrin are of great importance and have been the subject of many multidisciplinary studies since the 1940's. One aspect of fibrin formation that has remained poorly understood is the earliest stage in the process, wherein the thrombin-activated fibrinogen molecules polymerize in solution. During this earliest stage the intermediate fibrin polymers are produced, which are the precursor polymers for the distinctly later fibrin products the fibrils and fibres.
This problem has been approached indirectly, in the past, because of the general belief that fibrin molecules are insoluble under physiological conditions (Shainoff & Page, 1960) , because of their presumed uncontrolled tendency to aggregate into insoluble networks. Accordingly, the intermediate fibrin polymers have been presumed to represent unstable transient intermediates that could be studied in solution only in the presence of polymerization inhibitors, in the presence of chaotropic agents, or hydrogen-bond-breaking solvents or in solutions of non-physiological pH values (for reviews see Scheraga & Laskowski, 1957;  Doolittle, 1973) .
The purpose of the present work was to elucidate the mechanism(s) of fibrin polymerization in solution by directly studying the fibrinogen-thrombin reaction under nearly physiological conditions (370C, pH7.4 and in 0.15 M-or 0.3 M-NaCI). The experimental aims were to use gel chromatography to observe and to fractionate the various soluble molecular populations evolving during the fibrinogen-fibrin conversion and to physically and chemically characterize the soluble fibrin oligomers. The premise for this approach was that the soluble products of the polymerization phase of the fibrinogen-fibrin conversion might not be labile under these conditions, rather they might be sufficiently stable for direct study in solution. This premise was based on findings by Smith & Bang (1972) , working with aqueous buffered clotting systems, and on observations by other workers on blood plasma-clotting systems (Kierulf & Abildgaard, 1971; Ly & Jakobsen, 1975 ) and on blood plasma from patients (Alkjaersig et al., 1975; Edgar et al., 1977) . Each of these studies had strongly suggested that polymeric forms of fibrin do exist in solution under physiological conditions.
Materials and Methods

Human fibrinogen
Fibrinogen was isolated from a 2 litre pool of human citrate-treated plasma (not yet past the 'expiration date'), purchased from a local hospital blood bank, by combination of the methods of Kazal et al. (1963 Kazal et al. ( , 1964 , Mosesson & Sherry (1966) and Mosesson (1962) . Only variations from these procedures are described below. Plastic containers were used for all operations. Solid 6-aminohexanoic acid (Sigma) was added to the plasma, to a concentration of 0.1 M, immediately on pooling. After centrifugation to remove cell debris, the plasma was treated three times by BaSO4 adsorption (J. T. Baker powder) at successive concentrations of 90g/litre, 90g/litre and 45g/litre. After each I h adsorption period and centrifugation at 5000g, the plasma was tested for thromboplastin-clotting time (0.1 ml of plasma plus 0.1 ml of Dade thromboplastin reagent) and recalcification-clotting time [O.1 ml of plasma+ 0.1 ml of CaCI2 (0.02M, containing 0.2M-6-aminohexanoic acid)]. After the third BaSO4 treatment, the recalcification-clotting time was infinite (greater than 4 days, when observation was ceased) and the thromboplastin-clotting time was >lOh. This plasma was then treated by the methods cited in the above references with Matheson glycine crystals, maintaining the 6-aminohexanoic acid concentration at 0.1 M in all of the solutions during all operations, to isolate the fibrinogen as fractions I-l, 1-2, I-8 and I-9. Only fibrinogen fraction 1-2, the so-called lowsolubility, or normal, fibrinogen molecular population, was used in the experimental work described in the present paper. The isolated fibrinogen 1-2 was dialysed against 0.06M-Tris/0.3M-NaCl (pH 7.4) and stored frozen. The fibrinogen was free from plasmin, plasmin inhibitor, thrombin inhibitor, heparin cofactor, plasminogen and factor XIII, as judged by the absence of these activities in the following assays: plasmin, no thrombin-clot lysis over an extended time period; plasminogen, no thrombin-clot lysis with urokinase and no fibrinogen lysis with urokinase as judged by immunoelectrophoresis and gel chromatography; plasmin inhibitor, no ability to change standard plasmin activity on fibrin-plate assay; thrombin inhibitor, no ability to inhibit thrombin hydrolysis of Bz-Phe-Val-Arg-pNA; heparincofactor, no ability to increase the inherent heparin thrombininhibition activity in the presence of heparin (Smith, 1977) ; factor XIII, no 5M-urea-insoluble fibrin and covalently bound chains in fibrin on SDS/dithiothreitol/lO% polyacrylamide-gel electrophoresis. Fraction 1-9 was used as a molecular-weight standard (275000) for gel chromatography. Thrombin Bovine thrombin was purified from Parke Davis topical thrombin by the methods of Rasmussen (1955) and McCoy et al. (1974) and was assayed by plasmaclotting kinetics against N.I.H. reference human thrombin (lot 3-B) and found to have an activity of 2200 N.I.H. units/mg (Smith & Craft, 1976) . The thrombin was judged to be free of a2-antithrombin by SDS/polyacrylamide-gel electrophoresis. In the experiments described in the present paper the same results were obtained by using either purified thrombin or the crude topical thrombin. Thrombin was dissolved in 0.06M-Tris/0.3 M-NaCI (pH 7.4).
Gel chromatography
Agarose-gel columns were prepared from Bio-Gel A (Bio-Rad , 1970 and 
Fibrinogen-fibrin conversion in solution
The dynamic molecular polymerizations occurring during the thrombin-induced fibrinogen-fibrin conversion (from incipient thrombin action until gelation) are demonstrated by the analytical-gelchromatography curves in Fig The reaction mixture was too viscous to sample after 220min reaction time. Therefore the t = 220 min curve represents the molecular state of affairs in the fibrinogen-fibrin conversion just before gelation (or clotting). Just before coagulation in this unstirred reaction essentially all the fibrinogen was activated and incorporated into soluble fibrin polymers.
The portions taken at the various times for analysis in Fig. 1 all showed complete recovery of total protein during gel chromatography, showing that no fibrin precipitation occurred at any point in the reaction before the gel point (240-270min). Hence the sequence of analytical curves in Fig. 1 represents the total distribution of molecular species during the fibrinogen-fibrin conversion at pH 7.4, 0.15-0.3 MNaCl and 37°C. For data in 0.15M-NaCI buffer see below.
Experiments such as that shown in Fig. I were performed in which portions of the reaction mixtures, having been treated with NpGdBzO-(or hirudin), were left at room temperature for 24h, or were frozen and stored for 1-4 days to be thawed and analysed. In all cases the gel-elution patterns of the portions were not changed. Thus on stopping the thrombin enzymic catalysis in a thrombin-fibrinogen reaction mixture, the various ongoing individual polymerization reactions immediately cease and the molecular array of products is 'frozen'. This implies that the polymerization reactions between activated species are extremely fast and that the rate-controlling step and the driving force of the whole process is the continual thrombin activation of all the species in solution. When thrombin is added back to any of the stopped reactions the mixtures proceed to form fibrin clots.
When using the same experimental approach to examine the fibrinogen-thrombin reaction in 0.15M-NaCl buffer, there were no discernible differences from the experiments conducted in the 0.3M-NaCl buffer (the same soluble fibrin oligomers were formed in the same sequence with the same properties). The overall reaction rate is about 1.3 times faster in the lower ionic-strength medium. This difference in total reaction rate in the two ionic-strength environments is simply due to ionic effects on thrombin catalytic activity, since the same rate difference was found when measuring the thrombin hydrolysis of Bz-PheVal-Arg-pNA at 0.15 and 0.30 ionic strengths. This is consistent with previous observations that thrombin-proteolytic activity on a variety of substrates is similarly affected by similar variations in ionic strength (Sherry et al., 1954; Blomback, 1958; Svendsen et al., 1972) .
Preparative fractionation ofsoluble fibrin polymers
The remarkable stability of the various soluble fibrin polymers (see above) suggested that they could be isolated by preparative gel chromatography. The experiment described in Fig. 2 demonstrates the production and fractionation of soluble fibrin polymers. This fibrinogen-thrombin reaction was allowed to progress to a point where the various classes of soluble oligomers would show measurable populations, e.g., to a point represented by the t = 60 min curve of Fig. 1 , and the reaction was terminated at that point. A small portion was taken for analytical gel chromatography to confirm that the spectrum of soluble fibrin products was, indeed, similar to the t = 60min curve of Fig. 1 . The whole stopped-reaction mixture was fractionated on a preparative column of Bio-Gel A-Sm (Fig. 2a) . The void volume of the column in Fig. 2(a) was about 50ml and control fibrinogen was eluted from the column as a single symmetrical peak (broken curve) at about 90 ml. The preparative elution pattern (solid curve) shows that, indeed, a spectrum of soluble molecules of various molecular weights was fractionated in this experiment, ranging from fibrinogen-sized molecules (80-100mI elution) to much larger molecules eluting at the void volume. The fraction numbers 5, 10, 15, 20, 25, 30, 35 and 40, as indicated in Fig. 2(a) , were selected for analytical study. Fig. 2(b) shows the analytical gel chromatography of these fractions (1 ml portions).
In Fig. 2 (b) the elution of control fibrinogen is shown by the broken curve, a single symmetrical peak at 11.8ml elution volume (the void volume of the column used was about 7.0ml). The only void-volume polymers and some f1 fibrin molecules, but has no fibrin dimer population. The analytical-gel chromatograms of Fig. 2 (b) were obtained immediately on isolation of the various fractions from the preparative chromatography. However, these same fractions were then frozen and rechromatographed after thawing. The resulting curves were identical with those of Fig. 2(b) . These thawed fractions were left overnight at room temperature for a third series of analytical chromatography, and again the gel-elution patterns were identical with those of Fig. 2(b) . Therefore the oligomeric soluble fibrin polymers demonstrate extreme stability, tending to neither dissociate nor to further aggregate when fractionated into various molecular-sized populations. The results described in Fig. 2 are also obtained when performing the fibrinogen-thrombin reaction at 0.15 ionic strength, except that the total reaction rate is slightly faster (see above).
Sedimentation coefficients (S20,W) of soluble fibrinpolymerfractions Ultracentrifugal analysis of fractions from the experiment in Fig. 2 and from a number of other similar experiments with A-15m agarose preparative gel chromatography yielded the 520,w values (0.1-0.5mg of protein/ml): fibrinogen (e.g. fraction 39, Fig. 2 ), 7s; fibrin dimer (e.g. fraction 15, Fig. 2 ), 12S; f. polymers (e.g. fraction 10, Fig. 2 ), 17S ;f,.Id polymers (e.g. fraction 5, Fig. 2 ), 23S.
Non-covalent nature of the intermolecular bonding within soluble fibrin polymers The extremely strong intermolecular bonding that allows the soluble fibrin polymers to be isolated, and to be diluted (during gel chromatography) without detecting dissociation, was shown to be non-covalent in character. Fig. 3 , for example, shows the 10% polyacrylamide-gel electrophoresis in the presence of0.1 % SDS, intramolecular disulphide bonds having been broken by dithiothreitol. The electrophoretic gels in Fig. 3 show control fibrinogen and three fractions of soluble fibrin polymers from a preparative experiment exactly like that in Fig. 2(a) (the fibrin samples correspond to fractions 5, 10 and 15 in Fig. 2a) . The three soluble fibrin samples show only bands similar to the Aa-, Bf6-and y-chains of the fibrinogen sample.
Absolutely no covalent linkage exists between or among any of the chains, as covalent bonding would have produced slower moving protein bands in the gels (this type of analysis is commonly utilized to discriminate between cross-linked and non-crosslinked chains in fibrin). Many soluble fibrin fractions have been analysed in this fashion, including all of the fractions discussed in Figs. 2(a) and 2(b) . In all cases, all of the fibrin polymers isolated and characterized (f,oId, f, and f2 dimer) analyse exactly as the Fig. 3 . 10% polyacrylamide/SDS-gel discontinuous electrophoresis with disulphide bond-reduced samples Samples were isolated fractions from a stopped fibrinogen-thrombin reaction identical with the conditions and preparative chromatography described in the legend to Fig. 2 Of the six chains in fibrinogen, four are thrombinsusceptible, namely, the two Aa-chains (N-terminating in alanine) and the two Bfi-chains (N-terminating in 5-oxoproline). Each thrombin-activation event proteolytically cleaves an arginylglycine bond, producing a new glycine N-terminal group, whereas the original N-terminal residue leaves as part of the activation peptide. The two fibrinogen y-chains have N-terminal tyrosine residues. Phenyl isothiocyanate will not react with 5-oxoprolyl end-groups. Hence fibrinogen yields the pattern alanine/tyrosine residues (2: 2) per 340000 molecular weight; if one A-fibrinopeptide is cleaved, the resulting molecule yields alanine/glycine/tyrosine residues (1:1:2) per 340000 molecular weight; if both A-fibrinopeptides and both B-fibrinopeptides are cleaved, the resulting molecule yields glycine/tyrosine residues (4:2) per 340000 molecular weight.
Since it was now possible to isolate stable fibrin oligomers from the fibrinogen-fibrin conversion, the extent of thrombin activation could be determined by quantitatively measuring the N-terminal amino acids in the isolated soluble fibrin-polymer fractions. Thus preparative fibrinogen-fibrin-conversion reactions were designed to isolate sufficient quantities samples of Fig. 3 Humanfibri.nogen (3.5 ml; 7.1 mg/ml) was treated with thrombin (0.014 N.I.H. units/ml) at pH7.4 and 37°C for 40min, the reaction being stopped with NpGdBzO-. The extent of reaction was shown to be between the t = 30min and the t = 60min curves of Fig. 1 . The stopped-fibrinogen-fibrin-conversion mixture was fractionated on a preparation column of A-5 m agarose. The preparative-gel-elution pattern is shown in Fig. 4 as the solid curve (the elution of 25mg of control fibrinogen from that column is shown by the broken curve). The pooled fractions for N-terminal amino acid analysis are indicated by the vertical broken lines and the N-terminal amino acids found in the pooled fibrin oligomeric fractions are indicated in their respective elution region. The N-terminal data are given in residues/340000 molecular weight (the molecular size of fibrinogen). The elution characteristics of this preparatory column (Fig. 4) are as follows. Fibrinogen is eluted from 85 to 115 ml, fibrin dimer is eluted from 70 to 90ml and f,.Id polymers (and f. polymers) are eluted from 55 to 75 ml. The eluent flow was 0.53 ml/min.
The pooled fraction VI, containing only fibrinogensized protein, showed an N-terminal amino acid content oftwo alanine and two tyrosine residues/mol; only unactivated fibrinogen molecules are present in this pool and fibrin monomers (which would be detectable by their N-terminal glycine) are not present. This shows that fibrin monomers that are generated by thrombin action are too reactive to remain 'monomeric' in solution, the 'monomers' very rapidly, and irreversibly, dimerizing to the stable fibrin dimer.
The elution region for fibrin dimer on the preparatory column of Fig. 4 is spanned by the three pooled fractions II, III and IV. On the basis of analytical gel chromatography fibrin dimer was the exclusive component of zones III and IV and was the main component of zone II (with some overlap with f. and f,.id polymers). The N-terminal amino acid pattern demonstrated by the fibrin dimer population in each pooled fraction is alanine/glycine/tyrosine residues (1:1:2) per mol of fibrinogen subunit (mol.wt. 340000). The chemical composition of fibrin dimer is defined therefore as the dimer of two minimally thrombin-activated fibrinogen molecules (each having lost one A-fibrinopeptide); i.e.
(Y)2(Bfi)2(Aia)(a)-{a)(Aa)(BP)2(Y)2.
The fibrin polymers in the fraction I of Fig. 4 were all (fVOId-fX)-sized species; no fibrin dimer (or other smaller molecule) was present. The N-terminal amino acids found in the fv.id-fx polymers of fraction I, Fig. 4 , had alanine/glycine/tyrosine residues (0.6:1.0:20) per 340000 molecular weight. It has been shown that the N-terminal analytical technique used should produce data with an error of no more Vol. 185 than 10% with fibrinogen and fibrin (Smith, 1968; Smith & Murray, 1970) . In spite of the quantitative uncertainty that is apparent in this particular result, valuable qualitative deductions can be made. The N-terminal pattern shows significant N-terminal alanine (uncleaved A-fibrinopeptides) in these inert f,oId fibrin polymers. This demonstrates that the large soluble fibrin molecules, although they are inert to further spontaneous polymerization (they have used up the active surfaces revealed by thrombin), possess Aa-chains, which can later be activated by thrombin.
Discussion
A direct study ofthe earliestphaseofthefibrinogenfibrin conversion, fibrin polymerization in solution, has been reported in the present paper. It was demonstrated that, indeed, this process mediated by thrombin under nearly physiological conditions (pH7.4 and ionic strength 0.3 or 0.15) can be experimentally monitored without altering the reaction environment from the beginning of thrombin proteolysis until gelation of the reaction mixture.
The experiments of Figs. 1 and 2 are positive proof that the intermediate fibrin polymers are soluble stable (indeed, inert) molecules. These stable soluble fibrin polymers are the precursor polymers for the distinctly later fibrin products the fibrils and flbres. The intermolecular associations within the soluble fibrin polymers (including the fibrin dimer) were found to be essentially irreversible at pH7.4 and ionic strength 0.15 or 0.3. However, it was demonstrated that the intermolecular bonds within the soluble fibrin oligomers are not covalent.
The fact that the soluble fibrin oligomer formation was not effected by changing the ionic-strength environment from 0.15 to 0.30 (except for the total reaction rate as governed by small changes in thrombin activity) contrasts with the significant effects produced in fibrin fibril structure by these same subtle changes in ionic strength (Shen et al., 1977) . This contrast suggests that the mechanism whereby the activated fibrinogen molecules associate into soluble fibrin polymers is different from the mechanism(s) whereby the soluble fibrin polymers associate to form fibrils and fibres. In support of this difference in association mechanisms is the recent finding (G. F. Smith & J. L. Sundboom, unpublished work) that Ca2+ (0.0025M) in experiments identical with that of Fig. 1 (0.15M-NaCI) does not alter the results, but that the resulting clot formed is very opaque (in contrast with the clear clot formed without added Ca2+). Thus the effect of Ca2+ on fibrin-clot opacity is not mediated during soluble fibrin polymerization; rather, the effect operates during fibril or fibre formation. Manyakov et al. (1977) have suggested that many, if not most, of the interactions involved in fibril formation occur beyond the gelation point (possibly involving subunit rearrangements).
It was also shown that the entire fibrin-polymerization process is kinetically controlled by thrombin activity. As long as a thrombin activity persists, or if thrombin is reintroduced into stoppedreaction mixtures, the fibrinogen-fibrin conversion will be driven forward, but stopping the thrombin activity will arrest the process.
We were able to separate the products of the fibrinogen-fibrin conversion (stopped at about onequarter of the gelation time). The fibrinogen-sized molecules (s2o,W = 7S) had only alanine and tyrosine N-terminal residues (no glycine). Fibrin dimer (s2o,w = 12S) had the N-terminal pattern of alanine/ glycine/tyrosine residues (1:1:2) per 340000 molecular weight. The soluble fibrin polymers larger than fibrin dimer were separated into two rough classifications, fx (s20,w = 17S) and f,.1d (s20.w = 23S).
These mixtures of soluble fibrin polymers contained a significant amount of N-terminal alanine when isolated at this early stage (one-quarter of the gelation time), showing the existence of intact Aa-chains within these soluble fibrin polymers.
The fibrin dimer, on the basis of its N-terminal content, could only have been composed by the combination of two (a)(Aa)(Bfl)2(y)2 fibrin monomers, or from the stoichiometric combination of one(A)2(Bf2-(Y)2 fibrin monomer and one unaltered fibrinogen (Aa)2(Bf)2(y)2. Benabid et al. (1977) isolated a noncross-linked fibrin dimer (pH 8.5) and found it to have two intact A-fibrinopeptides and four intact B-fibrinopeptides. This is absolute proof that fibrin polymerization begins on incomplete thrombin activation of fibrinogen. The fibrin dimer model that stoichiometrically contains an unaltered fibrinogen molecule can be rejected on rational and experimental grounds. Rationally, if thrombin activation (removal of the fibrinopeptides) is required to expose an active polymerization surface (or to allow the formation of an active surface) in the fibrin monomer, then no such surface would be available on unactivated fibrinogen molecules; therefore there would exist no driving force for these unactivated fibrinogen molecules to participate in the irreversible association reactions we have observed. Also thrombin proteolysis of both Aa-chains in one fibrinogen in the presence of a huge excess of intact fibrinogens early in the reaction would be required. Another requirement would be that the valency induced by this double proteolysis is completely satisfied by a single contact with an unaltered fibrinogen molecule to yield a dimer that would be electrically neutral and inert. These constraints are difficult to accept in favour of the simple combination of two (ac)(Aa)(Bl2(y)2 activated monomers. Experimentally, it has been shown that the soluble fibrin polymers formed under the conditions of Fig. 1 , just before the gelation point (when no fibrinogen-sized molecules remain), contain only traces of N-terminal alanine, whereas at about one-quarter of the gelation time soluble fibrin polymer molecules contain about 0.4 residue of alanine/340000 molecular weight (Smith & Bang, 1972; Smith, 1979) . These data preclude the possibility for fibrinogen being a stoichiometric co-reactant in the formation of these soluble polymers. Also, experiments have been conducted whereby soluble fibrin polymer fractions (carefully isolated, including all the various molecular size populations, e.g. the fractions shown in Fig. 2b ) and fibrinogen molecules have been incubated together for various periods of time (ranging from I h to 3 days) and the mixtures analysed by gel chromatography. The relative concentrations of fibrinogen and soluble fibrin in the experiments were varied from equimolar to large excesses of either component. The experiments were performed with radioactively labelled fibrinogen mixed with unlabelled soluble fibrin polymers, and with radioactively labelled soluble fibrin mixed with unlabelled fibrinogen. In all experiments analytical gel chromatography showed no interaction between fibrinogen and any of the soluble fibrin polymer molecules (G. F. Smith, unpublished work; Smith & Craft, 1974) .
Therefore I conclude that unaltered fibrinogen is not a component of the stable fibrin dimer or of any soluble fibrin polymer. Accordingly, fibrin polymerization must begin after only one Aa-chain is activated by thrombin and the first soluble polymer is a dimer formed by the self-association of two (x)(Aa)(Bf)2(y)2 fibrin monomers.
The mechanism of fibrin polymerization, deduced from the present work, is depicted in Fig. 5 .
It is most reasonable to visualize the formation of fibrin dimer as a reciprocal alignment of two fibrin monomers such that their active surfaces (somehow accessible after loss of one A-fibrinopeptide) complementarily interact (utilizing hydrophobic and electrostatic bonding and hydrogen-bonds). This type of complementary or reciprocal association would readily explain the inertness or 'dead-end' nature of the soluble fibrin oligomers, for the active surfaces would be mutually neutralized, leaving only unactivated Aa-chains (and B,B-chains) exposed for future thrombin activation. Also this type of reciprocal alignment would agree with the elegant finding of Doolittle et al. (1972) , who demonstrated that the chains of adjacent fibrin subunits of cross-linked fibrin (cross-linked by factor XIlla) were reciprocally orientated from the C-terminal ends of the y-chains.
It has been well established that thrombin removes the A-fibrinopeptides from fibrinogen much faster than the B-fibrinopeptides (Bettleheim, 1956; Laurent & Blomback, 1958) .
Therefore the growth of the soluble fibrin polymers is postulated to (Doolittle et al., 1972) , the localization of the fibrinopeptides at the centre portion of the molecule ) and the faster release of A-fibrinopeptides compared with B-fibrinopeptides (Laurent & Blomback, 1958) . the remaining Aa-chains on the fibrin dimer, followed by rapid reciprocal associations between the activated dimer species and other activated species generated in the thrombin-driven reaction mixture. Each time a reciprocal association occurs, the product of the association (a fibrin oligomer) becomes an inert, or 'dead-ended', molecule, requiring thrombin for further activation (each stable polymer would have an Aa-chain at either end and a large number of BPi-chains along its length). In this fashion progressively larger fibrin polymers are built up and thrombin is constantly in control over the irreversible process. The condition for gelation is simply the asymmetry of the growing soluble fibrin polymers (Flory, 1972; Nelb et al., 1976) , and this condition is known to require only the release of fibrinopeptide A (Laurent & Blomback, 1958) . The associations of the soluble Vol. 185 fibrin polymers into fibrils and the corresponding role of the activation sites liberated by fibrinopeptide B release are beyond the experimental scope of the present paper. These issues have been discussed in the work of Blomback et al. (1978) , who suggest that fibrin polymeric structures are a prerequisite for fibrinopeptide B release, and of Shen et al. (1977) , who suggest that the fibril-fibre structural dimensions are dependent on fibrinopeptide B release.
The mechanism of fibrin polymerization reported in the present paper suggests that stable fibrin polymers are progressively constructed in an orderly way and that sequential thrombin activation controls the process. This, in turn, suggests that the bulk of thermodynamic, kinetic and physical observations that were made with systems of dispersed clotted fibrin may not be valid, since the reaggregation of fully activated subunits can follow pathways not allowed during the sequential activation process. However, the discovery that the soluble fibrin polymers are stable at pH7.4 and 0.15M-NaCl will afford the opportunity to re-examine the fibrinpolymerization reactions from many experimental approaches, under these nearly physiological conditions.
The experimental thrombin concentrations used in the present study were similar to that expected to be generated in blood (Nemerson et al., 1974; Rosenberg et al., 1975) . Moreover, it has been shown that these concentrations of thrombin are required to produce fibrin fibres, which are microscopically indistinguishable from fibres isolated from human arterial thrombi (Buchanan et al., 1977) .
Also, the stable fibrin-like polymers observed in patients' plasma (Kierulf & Godal, 1972; Graeff et al., 1973; Donati et al., 1976; Edgar et al., 1977) can be accounted for by this mechanism. Not only is it no longer necessary to explain fibrin solubility by invoking hypothetic fibrinogen-fibrin 'complexes' (Shainoff & Page, 1960 , 1962 Fletcher et al., 1977; Sherman, 1977) , but also any such 'complex' hypothesis will have to be justified in the light of the present demonstration that fibrin polymers are soluble and stable under physiological conditions.
